Topic: Blood Disorders
Ligand Pharmaceuticals Inc. said Friday that partner GlaxoSmithKline gained European regulatory approval to sell the blood disorder drug Revolade. In December, a European advisory committee recommended approving the drug. It was discovered by Ligand, is already approved in the U.S. as Promacta. Ligand's licensing partner GlaxoSmithKline handled the European ...
Polycythemia is a medical term used when the red blood cell count increases in the blood. Or the same could be understood as the decreased volume of plasma in the blood. There are two kinds of Polycythemia - Polycythemia Vera &secondary Polycythemia. The former is the result of the bone marrow disorder. It is the bone marrow is where the red ...
CHICAGO (Reuters) - Aggressive treatment with blockbuster anemia drugs may offer the best approach for kidney dialysis patients with severe anemia, U.S. researchers said on Tuesday. But aggressive treatment only made things worse for patients in the final stages of kidney disease with mild anemia, they reported in the Journal of the American Medical Association. The findings may help guide ...
